Bager C, Blair J, Tang M, Mortensen J, Bay-Jensen A, Frederiksen P
Sci Rep. 2023; 13(1):23039.
PMID: 38155185
PMC: 10754934.
DOI: 10.1038/s41598-023-50313-y.
Mitra S, Harvey-Jones K, Kraev I, Verma V, Meehan C, Mintoft A
Int J Mol Sci. 2023; 24(14).
PMID: 37511288
PMC: 10380774.
DOI: 10.3390/ijms241411529.
DAlessio S, Cheng H, Eaton L, Kraev I, Pamenter M, Lange S
Int J Mol Sci. 2022; 23(9).
PMID: 35563075
PMC: 9100269.
DOI: 10.3390/ijms23094683.
Ahmed D, Puthussery H, Basnett P, Knowles J, Lange S, Roy I
Int J Mol Sci. 2021; 22(23).
PMID: 34884657
PMC: 8658019.
DOI: 10.3390/ijms222312852.
Jehan F, Sazawal S, Baqui A, Nisar M, Dhingra U, Khanam R
JAMA Netw Open. 2020; 3(12):e2029655.
PMID: 33337494
PMC: 7749442.
DOI: 10.1001/jamanetworkopen.2020.29655.
Putative Roles for Peptidylarginine Deiminases in COVID-19.
Arisan E, Uysal-Onganer P, Lange S
Int J Mol Sci. 2020; 21(13).
PMID: 32629995
PMC: 7370447.
DOI: 10.3390/ijms21134662.
Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage.
Bustelo M, Barkhuizen M, van den Hove D, Steinbusch H, Bruno M, Loidl C
Front Neurol. 2020; 11:483.
PMID: 32582011
PMC: 7296108.
DOI: 10.3389/fneur.2020.00483.
Deimination Protein Profiles in Reveal Plasma and Extracellular Vesicle-Specific Signatures Relating to Immunity, Metabolic Function, and Gene Regulation.
Criscitiello M, Kraev I, Petersen L, Lange S
Front Immunol. 2020; 11:651.
PMID: 32411128
PMC: 7198796.
DOI: 10.3389/fimmu.2020.00651.
Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M, Uysal-Onganer P, Kraev I, Mercer A, Lange S
Int J Mol Sci. 2020; 21(8).
PMID: 32326590
PMC: 7215947.
DOI: 10.3390/ijms21082743.
Post-Translational Protein Deimination Signatures in Serum and Serum-Extracellular Vesicles of Reveal Immune, Anti-Pathogenic, Anti-Viral, Metabolic and Cancer-Related Pathways for Deimination.
Criscitiello M, Kraev I, Lange S
Int J Mol Sci. 2020; 21(8).
PMID: 32325910
PMC: 7215346.
DOI: 10.3390/ijms21082861.
Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P, Maclatchy A, Mahmoud R, Kraev I, Thompson P, Inal J
Int J Mol Sci. 2020; 21(4).
PMID: 32098295
PMC: 7073130.
DOI: 10.3390/ijms21041495.
Protein Deimination and Extracellular Vesicle Profiles in Antarctic Seabirds.
Phillips R, Kraev I, Lange S
Biology (Basel). 2020; 9(1).
PMID: 31936359
PMC: 7168935.
DOI: 10.3390/biology9010015.
HBO Promotes the Differentiation of Neural Stem Cells via Interactions Between the Wnt3/β-Catenin and BMP2 Signaling Pathways.
Chen C, Yang Y, Yao Y
Cell Transplant. 2019; 28(12):1686-1699.
PMID: 31694396
PMC: 6923559.
DOI: 10.1177/0963689719883578.
Post-Translational Deimination of Immunological and Metabolic Protein Markers in Plasma and Extracellular Vesicles of Naked Mole-Rat ().
Pamenter M, Uysal-Onganer P, Huynh K, Kraev I, Lange S
Int J Mol Sci. 2019; 20(21).
PMID: 31671738
PMC: 6862702.
DOI: 10.3390/ijms20215378.
Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage U, Uysal-Onganer P, Maclatchy A, Kraev I, Chatterton N, Nicholas A
Int J Mol Sci. 2019; 20(1).
PMID: 30597867
PMC: 6337164.
DOI: 10.3390/ijms20010103.
Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?.
Lange S, Gallagher M, Kholia S, Kosgodage U, Hristova M, Hardy J
Int J Mol Sci. 2017; 18(6).
PMID: 28587234
PMC: 5486019.
DOI: 10.3390/ijms18061196.
[The neuroprotective role of exogenous TERT gene in neonatal rats with hypoxic-ischemic brain damage].
Zhao F, Qu Y, Zhang L, Huang L, Liu H, Li J
Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(12):1296-1301.
PMID: 27974126
PMC: 7403081.